AXOGEN, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.04 USD | +1.17% |
|
+5.04% | -11.57% |
| 05-16 | AxoGen Initiates Rolling Submission to FDA For Avance Nerve Graft | MT |
| 05-02 | Transcript : AxoGen, Inc., Q1 2024 Earnings Call, May 02, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Advanced Medical Equipment & Technology
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 264M | - | - | - | |||
| 227B | ||||||
| 197B | ||||||
| 141B | ||||||
| 110B | ||||||
| 64.15B |
- Stock Market
- Equities
- AXGN Stock
- Charts AxoGen, Inc.
- Sector Chart